In vivo neurochemistry of primary focal hand dystonia: A magnetic resonance spectroscopic neurometabolite profiling study at 3T

Movement Disorders

Volumn 25, Issue 16, 2010, Pages 2800-2808

  Herath, Priyantha ^a   Gallea, Cecile ^a   Van Der Veen, Jan Willem ^b   Horovitz, Silvina G ^a   Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

Author keywords

Dystonia; Gamma amino butyric acid (GABA); Imaging; Magnetic resonance spectroscopy; Metabolic profile

Indexed keywords

4 AMINOBUTYRIC ACID; GLUTAMIC ACID; GLUTAMINE; NEUROTRANSMITTER;

ADULT; AGED; ARTICLE; BASAL GANGLION; BRAIN REGION; CLINICAL ARTICLE; CONTROLLED STUDY; FOCAL HAND DYSTONIA; HUMAN; IN VIVO STUDY; METABOLITE; NEUROCHEMISTRY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SENSITIVITY ANALYSIS; SENSORIMOTOR CORTEX;

ADULT; AGED; BASAL GANGLIA; BOTULINUM TOXINS, TYPE A; CEREBRAL CORTEX; DYSTONIC DISORDERS; GAMMA-AMINOBUTYRIC ACID; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MIDDLE AGED; NEUROMUSCULAR AGENTS;

EID: 78650227717     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.23306     Document Type: Article

References (31)

1. Breakefield XO, Blood AJ, Li Y, Hallett M, Hanson PI, Standaert DG. The pathophysiological basis of dystonias. Nat Rev Neurosci 2008; 9: 222-234.
2. Hallett M. Pathophysiology of dystonia. J Neural Transm Suppl 2006;(70): 485-488.
3. Richter A, Löscher W. Pathology of idiopathic dystonia: findings from genetic animal models. Prog Neurobiol 1998; 54: 633-677.
4. Matsumura M, Sawaguchi T, Kubota K. GABAergic inhibition of neuronal activity in the primate motor and premotor cortex during voluntary movement. J Neurophysiol 1992; 68: 692-702.
5. Matsumura M, Sawaguchi T, Oishi T, Ueki K, Kubota K. Behavioral deficits induced by local injection of bicuculline and muscimol into the primate motor and premotor cortex. J Neurophysiol 1991; 65: 1542-1553.
6. Sohn Y, Hallett M. Disturbed surround inhibition in focal hand dystonia. Ann Neurol 2004; 56: 595-599.
7. Sohn Y, Hallett M. Surround inhibition in human motor system. Exp Brain Res 2004; 158: 397-404.
8. Levy LM, Hallett M. Impaired brain GABA in focal dystonia. Ann Neurol 2002; 51: 93-101.
9. McGeer PL, McGeer EG. Neurotransmitters and their receptors in the basal ganglia. Adv Neurol 1993; 60: 93-101.
10. Hauber W. Involvement of basal ganglia transmitter systems in movement initiation. Prog Neurobiol 1998; 56: 507-540.
11. Stacy M, editor. Handbook of Dystonia. New York: Informa Healthcare; 2006. p 1-440.
12. Fonnum F. Glutamate: a neurotransmitter in mammalian brain. J Neurochem 1984; 42: 1-11.
13. Bak LK, Schousboe A, Waagepetersen HS. The glutamate/GABA-glutamine cycle: aspects of transport, neurotransmitter homeostasis and ammonia transfer. J Neurochem 2006; 98: 641-653.
14. Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed 2000; 13: 129-153.
15. de Graaf RA. In Vivo NMR Spectroscopy: Principles and Techniques. New York: Wiley-Interscience; 2008.
16. Waddell KW, Avison MJ, Joers JM, Gore JC. A practical guide to robust detection of GABA in human brain by J-difference spectroscopy at 3T using a standard volume coil. Magn Reson Imaging 2007; 25: 1032-1038.
17. Choi I, Lee S, Shen J. Selective homonuclear Hartmann-Hahn transfer method for in vivo spectral editing in the human brain. Magn Reson Med 2005; 53: 503-510.
18. 1H NMR spectroscopy of individual human brain metabolites at moderate field strengths. Magn Reson Imaging 2003; 21: 1295-1302.
19. Mai JK, Paxinos G, Voss T. Atlas of the Human Brain. Third ed. New York: Academic Press; 2007.
20. Costanzo D, Trojsi F, Tosetti M, Schirmer T. Proton MR spectroscopy of the brain at 3T: an update. Eur Radiol 2007; 17: 1651-1662.
21. Sanacora G, Mason GF, Rothman DL, et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56: 1043-1047.
22. Shen J, Rothman DL, Brown P. In vivo GABA editing using a novel doubly selective multiple quantum filter. Magn Reson Med 2002; 47: 447-454.
23. 1H spectra with LCModel. NMR Biomed 2001; 14: 260-264.
24. Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med 1993; 30: 672-679.
25. Ye JC, Bresler Y, Moulin P. Cramer-Rao bounds for parametric shape estimation in inverse problems. IEEE Trans Image Process 2003; 12: 71-84.
26. Walker R, McNaught KSP, Perl D. Pathology of the dystonias. In: Stasy MA, editor. Handbook of Dystonias. New York: Informa Healthcare; 2007. p 65-94.
27. Shill H, Hallett M. Physiology of Primary Dystonia. In: Stacy MA, editor. The Handbook of Dystonias. New York: Informa Healthcare; 2007. p 54-65.
28. Chang L, Cloak CC, Ernst T. Magnetic resonance spectroscopy studies of GABA in neuropsychiatric disorders. J Clin Psychiatry 2003; 64( Suppl 3): 7-14.
29. van der Zeyden M, Oldenziel WH, Rea K, Cremers TI, Westerink BH. Microdialysis of GABA and glutamate: analysis, interpretation and comparison with microsensors. Pharmacol Biochem Behav 2008; 90: 135-147.
30. 1H NMR spectra of human brain. Magn Reson Med 1994; 32: 294-302.
31. Meunier A, Valabregue R, Marjanska M, et al. Metabolic abnormalities in human primary dystonia: a magnetic resonance spectroscopic study. Mov Disord 2009; 24( suppl. 1): S201.